(Q36070920)

12 August 2017

Retrospective evaluation of inhaled prostaglandins in patients with acute respiratory distress syndrome (English)

1 reference

acute respiratory distress syndrome

12 August 2017

1 reference

James M Camamo

1

1 reference

12 August 2017

Ruth H McCoy

series ordinal

2

1 reference

12 August 2017

Brian L Erstad

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

12 August 2017

1 reference

12 August 2017

25

1 reference

12 August 2017

2

1 reference

12 August 2017

184-190

1 reference

Acute respiratory distress in adults

12 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.184.56952

Adult respiratory distress syndrome: a systemic overview of incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.184.56952

Acute lung injury and the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.184.56952

21 January 2018

New therapies for ARDS.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.184.56952

The acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.184.56952

Thirty years of clinical trials in acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.184.56952

Role of exogenous surfactant in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.184.56952

Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.184.56952

Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. A prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.184.56952

A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.184.56952

Aerosolised prostacyclin in adult respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.184.56952

Nebulized prostacyclin (PGI2) in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.184.56952

Liposomal prostaglandin E sub 1 in acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.2.184.56952

10.1592/PHCO.25.2.184.56952

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference